← US–China Policy Research | Exclusive Insights

AISTIM / US–China Policy Research | Exclusive Insights

Oct 20 US-China Policy Research: USTR's China Chip 301 Conclusion, Russian Diesel Deal & Huang's Berlin Pitch

AISTIM

USTR concluded its China semiconductor Section 301 probe: no new chip tariffs before June 23, 2027, with foundational chips keeping zero duties for 18 months. Jensen Huang lobbied Germany's chancellor to ease AI regulation ahead of his GTC Berlin keynote. The PHLX Semiconductor index snapped an eight-day losing streak.

Window: Evening of Oct 19 to evening of Oct 20 (New York time; daily issue No. 24).

I. US Policy

1. USTR issues China semiconductor Section 301 determination (Oct 20, confirmed)
What happened: USTR published its determination in the China semiconductor Section 301 investigation (launched Dec 2024): no additional chip tariffs before June 23, 2027; foundational semiconductors keep zero tariffs for 18 months.
Takeaway: Near-term relief for the China-linked chip supply chain; memory/basic-chip and equipment order sentiment improves. The probe is closed, so long-term decoupling and supply-chain risk remain.
Source: USTR via bitrss, Oct 20.

2. Russia sanctions pause + diesel deal + Zelenskyy clash escalates (Oct 18-20)
What happened: (1) Trump said on Truth Social on Oct 18 he is waiving key provisions of the Sanctioning Russia and Iran Act (up to 500% tariffs on Russian goods; passed by Congress in September, set to take effect Oct 18) to "keep Russia at the table." Secretary Rubio spoke of a roughly 60-day pause to assess economic impact, though the waiver has no explicit expiry. (2) Russian diesel deal: Russia will initially release about 300,000 tonnes (~2.25M barrels) of diesel to the US and global markets, potentially more later; Bloomberg reported on Oct 20 that members of Congress oppose the deal. (3) Trump posted that Zelenskyy "doesn't want to end the war"; Zelenskyy told NBC on Oct 18 that siding with Putin would be a "historic mistake."
Note: The "6 million barrels" figure cited in the previous issue has no public source this round and is withdrawn.
Source: theamericanstarnews, newscord, magnabureau, Bloomberg, CNBC, Oct 18-20 (cross-verified).

3. Fed rate-hike expectations, 22nd consecutive tracking (quiet period, no official remarks)
What happened: FOMC meets Oct 27-28; officials are in the blackout period with no public remarks. Warsh's Oct 16 remarks (last before the blackout) favored holding rates steady.
Latest data: CME FedWatch on Oct 20: ~83-85% odds of holding in October (~14-17% for a hike); ~89-94% for a December hike. Reuters economist survey Oct 16-20: 94 of 100 expect a hold in October, 100 of 100 expect a December hike. The 10-year Treasury closed Oct 19 at 5.14-5.15% and traded around 5.09% in the Oct 20 morning session; the 30-year mortgage sits near 7.40%.
Tracking line: Sep 28 (October hike 43%) → Oct 14 CPI release (intraday peak 51.5%) → Oct 19 (hike 13-18%) → this issue (hike 14-17%, hold 83-85%). The inflection point is set; expectations are stabilizing.
Source: CME FedWatch, Reuters, Bloomberg, Oct 16-20.

4. CIT approves IEEPA tariff refund class action (Oct 8 ruling, first covered this issue)
What happened: The US Court of International Trade approved a class action for IEEPA tariff refunds on Oct 8: about $166B of IEEPA duties have been paid, with roughly $30B still unclaimed.
Takeaway: If refunds proceed, the fiscal scale is enormous and would feed deficit and bond-market expectations; it also underlines the legal fragility of the IEEPA tariff architecture.
Source: Bloomberg Law, Mondaq.

5. Geopolitics and FCC/Fed personnel
(1) Iran-Hormuz: Kpler counted at least 18 ships attacked in the strait over the two weeks to Oct 20; the US says Gulf crude flows have recovered to ~80% of pre-war levels (Energy Secretary Wright, Fox News). Trump said there will be no Iran strike before the midterms (Nov 3). Oil: Brent Dec futures closed Oct 19 at $109.55 (-0.28%) and broke above $111 intraday on Oct 20 (a five-month high); WTI Nov closed Oct 19 at $103.66 (+2.22%). Spot gold traded $4,120-4,145/oz, down for a third straight session; the dollar index stood near 101.99.
(2) The FCC's Oct 29 meeting has two confirmed agenda items: voting to end FCC recognition of mainland China test labs (effective Dec 1, 2028; Chinese labs handled 82% of certification applications in 2025) and opening the 800MHz band for drones. No new signal on optical-module restrictions this round.
(3) Fed Governor Lisa Cook investigation committee: closed White House hearing on Nov 5 (capped at four hours, on the record); no new developments Oct 19-20.
Source: TradingKey, Bloomberg, Reuters, Reuters Oct 7 (FCC agenda), Reuters Oct 9 (Cook committee).

II. China Policy

1. NDRC releases first batch of 136 landmark application-scenario projects (Oct 20)
What happened: The NDRC published the first batch of 136 landmark major application-scenario projects covering scaled deployment of new technologies and products, pushing "AI+" deeper into real industries.
Takeaway: Demonstration projects accelerate; scaled replication expectations rise for AI applications, smart manufacturing, and intelligent connectivity.
Source: East Money/Sina Finance market close summary, Oct 20 (market-compiled, pending official ministry text).

2. MIIT: drafting next-generation smart manufacturing policy (Oct 20)
What happened: MIIT said it is drafting policy for next-generation smart manufacturing and is soliciting comments on five mandatory national standards including auto data-security requirements. The Ministry of Agriculture and Rural Affairs proposed using AI to empower breeding innovation.
Takeaway: The policy chain continues after the central government's Oct 9 "AI+" document; industrial automation, machine vision, and industrial software benefit long term.
Source: East Money/Sina Finance market close summary, Oct 20 (pending official ministry text).

3. 31st China-Russia regular prime-ministerial meeting underway (Oct 20-22)
What happened: Premier Li Qiang visits Russia Oct 20-22 for the 31st China-Russia regular prime-ministerial meeting, after Uzbekistan (Oct 17-18) and Tajikistan (Oct 18-20, SCO heads-of-government council).
Note: As of writing, no outcomes or joint communique have been published; search results currently return only previous rounds (28th-30th), which were excluded. To be tracked next issue.
Source: Xinhua itinerary preview Oct 15; MNI Oct 15.

4. NBS: Q3 GDP grew 4.5% YoY (Oct 20, confirmed)
What happened: At a State Council Information Office briefing on Oct 20: Q3 GDP grew 4.5% YoY, accelerating from 4.3% in Q2; "the national economy maintained stable operation."
Note: September industry/investment/consumption breakdowns were not yet available from authoritative sources this round.
Source: China.com.cn/Sina News, Oct 20.

5. Mortgage interest subsidy, 19th tracking round
New this round: The nationwide first-week official summary is still unpublished; explicitly noted, no old-news repetition.

III. US-Stock Watchlist (4 names this issue)

1. Amazon (AMZN, cloud/e-commerce)
Why watch: +5.00% on Oct 19; Morgan Stanley named it a top pick. AWS is a direct beneficiary of the AI cloud capex cycle.
Key data: No updated analyst price target retrieved this round; pending verification.
Risk: Capex intensity vs. return timing is uncertain; the consumer business remains exposed to macro swings.

2. Micron (MU, memory)
Why watch: A core play on the memory upcycle, +2.97% on Oct 19 as the sector rallied (SanDisk +5.53%, WD +6.09%, Hynix ADR +4.67%); AI-server and consumer-electronics memory demand is recovering.
Key data: No updated analyst price target retrieved this round; pending verification.
Risk: Memory is deeply cyclical; a price pullback would hit earnings directly; mature-node supply recovery is a risk.

3. Intel (INTC, semiconductors)
Why watch: Upgraded by JPMorgan, +2.4% on Oct 19; expected beneficiary of US domestic manufacturing policy.
Key data: No updated analyst price target retrieved this round; pending verification.
Risk: Foundry losses and cash-flow pressure; an unfavorable competitive position in AI accelerators.

4. CoreWeave (CRWV, AI compute leasing) — risk-warning case
What happened: The focal point of AI credit anxiety; the stock fell ~20% last week and -0.44% on Oct 19; its 2031 bonds yielded nearly 16% last week (~15.9% in the Oct 20 afternoon session), with 5-year CDS spreads around 1,000-1,085bp.
Counterpoint: JPMorgan said on Oct 20 that global bank exposure is limited ($10-30B across large US banks plus MUFG) and kept an "Overweight" with a $125 target; Janus Henderson called the selloff overdone.
Risk: A high-leverage, capital-intensive model; credit spreads could widen further in the AI capex "show-me-the-money" phase. Watch it as a sector risk barometer, not as a core holding.
Source: Reuters/CNBC, Oct 20.

IV. A-Share Watchlist (4 names; none previously featured in this mail series)

1. Montage Technology (688008, semiconductors/memory-interface chips)
Why watch: DDR5 penetration and generational upgrades plus AI-server "capacity" chips (MRCD/MDB, PCIe Retimer, CXL MXC) ramping; new-product revenue +80.7%; a beneficiary of domestic computing/storage self-sufficiency; the USTR Section 301 determination eases near-term tariff fears.
Key data: H1 revenue RMB 3.335B (+26.7%), net profit RMB 1.997B (+72.3%), gross margin 65.3%; Q2 revenue RMB 1.875B (+32.8%), net profit RMB 1.150B (+81.5%).
Risk: Net profit includes RMB 682M of non-recurring gains; core net profit was only RMB 1.322B (+21.2%) — real operating growth is far below the headline; P/E ~62x, down 19.43% over the past month, highly volatile; Q3 report due ~Oct 29, pending verification.
Source: Company H1 report, Aug 28 (verified).

2. AMEC (688012, semiconductor equipment/etch)
Why watch: Equipment localization keeps rising (etch/thin-film deposition localization above 40%); aggressive memory-fab expansion (CXMT/YMTC); its 90:1 ultra-high-aspect-ratio etch tool passed verification; the USTR determination eases tariff pressure.
Key data: H1 revenue RMB 6.69B; Q2 revenue RMB 3.776B (+35% YoY); R&D RMB 2.042B (30.52% of revenue); contract liabilities ~RMB 2.8B at end-Q2.
Risk: Of the H1 net profit of RMB 2.825B (nominal +300%), ~RMB 1.98B came from the one-off fair-value/investment gain on CXMT's July IPO; core operating profit was only ~RMB 1.0-1.2B; valuation is stretched (trailing P/E ~100-137x), down 21.23% over the past month; 60-70% of orders are memory-bound, heavily dependent on fab expansion pace and US controls; Q3 report due ~Oct 23, pending verification.
Source: Company H1 report (verified).

3. Inovance Technology (300124, industrial automation/robotics)
Why watch: The core domestic-substitution play in servos/drives/PLCs; AI industrial capex plus equipment exports are driving orders; at the Aug 31 earnings call, general-automation Q2 orders were ~+40% (July still +40%); its humanoid-robot components won customer designations, with small-batch motor shipments. The stock is down ~36% YTD (RMB 50.80 close on Oct 20), with a rolling P/E of ~28.5.
Key data: H1 revenue RMB 24.675B (+20.31%), net profit RMB 2.810B (-5.35%), core net profit RMB 2.756B (+3.15%); Q2 revenue RMB 14.532B (+26.02%), net profit RMB 1.796B (+9.14%).
Risk: H1 net profit fell 5.35% with profit growth trailing revenue; its EV drivetrain subsidiary United Power was notably under pressure in Q2 (weak demand, rising raw-material costs) and drove most of the H1 impairment; component price pressure continues; Q3 report due ~Oct 27, pending verification.
Source: Company H1 report / Aug 31 earnings call (verified).

4. BeiGene (688235, pharma/innovative drugs)
Why watch: Fits the "full-chain support for innovative drugs" policy framework; its zanubrutinib ranks No.1 in US BTK market share, proving the "global R&D, in-house commercialization" model; sonrotoclax received FDA approval in May 2026, awaiting ramp-up.
Key data: H1 revenue RMB 22.220B (+26.84%), net profit RMB 3.271B (+627.15%); first-ever annual profit in 2025, with H1 2026 profit 2.2x the full 2025 figure; overseas revenue 69.77%.
Risk: Valuation at historic highs — A-share TTM P/E ~86x, P/B ~10.4x, ~25% premium over the H-share; double concentration (zanubrutinib ~74% of H1 product revenue, US over half of revenue); patent cliffs and US IRA drug-price negotiations; full-year revenue guidance of 17.5%-20.9% (far below 2025's 40.4%); director Xiaodong Wang sold down over $24.68M in September; Hillhouse exited the 5%+ shareholder register.
Source: Company H1 report, Aug 5 (verified).

Screening note: Leadshine (688017, humanoid-robot reducers) was dropped for an extreme trailing P/E of ~349, dispersed ownership, and a slipping gross margin.

Previous-issue tracking (Oct 19: SMIC, TBEA, Guanghe, BOE A): BOE A — its controlling shareholder BOE Technology Group completed its RMB 1B top-up buyback on Oct 14 (186M shares, RMB 999.7M total), lifting its stake with concert parties to 13.08% (new this round). SMIC, TBEA, and Guanghe had no new public developments this round (TBEA: a new Linze electrical-equipment subsidiary announced Oct 13; Guanghe: board meeting on Oct 27 to review Q3 results). Yonyou Network's Q3 report is still undisclosed as of Oct 20 (H1: net loss of RMB 928M), a standing tracking item.


Risk note: This research is for informational purposes only and does not constitute investment advice. Investing involves risks; decisions require prudence.

*Improvements this issue (per the quality handbook): (1) Coverage: first-time inclusion of the USTR China semiconductor Section 301 determination (Oct 20) and the CIT IEEPA tariff-refund class action (Oct 8); (2) Data hygiene: withdrew the unsourced "6 million barrels" figure and a dated 2025 China-Russia meeting report; (3) Tracking: Fed expectations for the 22nd straight round (Sep-28 October-hike 43% → this issue 14-17%), the 19th mortgage-subsidy round honestly marked "no official summary," and Anthropic's S-1 still missing ahead of the Oct 23 window; (4) A-shares: all four refreshed against the dedup file (Northern Rare Earth excluded per the rule), each with reported figures, adverse disclosure, and an elimination log; (5) Previous-issue tracking: BOE A's completed buyback flagged as new, others marked "no new developments," and Yonyou's Q3 still pending.*